These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10772108)

  • 41. Acute and repeat-dose toxicity studies of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin (DOXO-EMCH), an albumin-binding prodrug of the anticancer agent doxorubicin.
    Kratz F; Ehling G; Kauffmann HM; Unger C
    Hum Exp Toxicol; 2007 Jan; 26(1):19-35. PubMed ID: 17334177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preclinical toxicology studies with nizatidine, a new H2-receptor antagonist: acute, subchronic, and chronic toxicity evaluations.
    Probst KS; Higdon GL; Fisher LF; McGrath JP; Adams ER; Emmerson JL
    Fundam Appl Toxicol; 1989 Nov; 13(4):778-92. PubMed ID: 2576009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toxicity of lactide in dogs after 2 and 13 weeks of daily oral dosing.
    Hébert CD; Giles HD; Heath JE; Hogan DB; Modderman JP; Conn RE
    Food Chem Toxicol; 1999 Apr; 37(4):335-42. PubMed ID: 10418951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Feasibility, safety, and tolerance of subcutaneous synthetic canine B-type natriuretic peptide (syncBNP) in healthy dogs and dogs with stage B1 mitral valve disease.
    Oyama MA; Solter PF; Thorn CL; Stern JA
    J Vet Cardiol; 2017 Jun; 19(3):211-217. PubMed ID: 28478943
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of twice-daily, low-dose trilostane treatment administered orally in dogs with naturally occurring hyperadrenocorticism.
    Vaughan MA; Feldman EC; Hoar BR; Nelson RW
    J Am Vet Med Assoc; 2008 May; 232(9):1321-8. PubMed ID: 18447776
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety evaluation of the interchangeable use of robenacoxib (Onsior™) tablets and solution for injection in dogs.
    Toutain CE; Heit MC; King SB; Helbig R
    BMC Vet Res; 2017 Nov; 13(1):359. PubMed ID: 29179750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute and short-term toxicoses associated with the administration of doxorubicin to dogs with malignant tumors.
    Ogilvie GK; Richardson RC; Curtis CR; Withrow SJ; Reynolds HA; Norris AM; Henderson RA; Klausner JS; Fowler JD; McCaw D
    J Am Vet Med Assoc; 1989 Dec; 195(11):1584-7. PubMed ID: 2599942
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease.
    Peddle GD; Singletary GE; Reynolds CA; Trafny DJ; Machen MC; Oyama MA
    J Vet Cardiol; 2012 Mar; 14(1):253-9. PubMed ID: 22364690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
    Häggström J; Hansson K; Karlberg BE; Kvart C; Madej A; Olsson K
    Am J Vet Res; 1996 Nov; 57(11):1645-52. PubMed ID: 8915446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of short-term anti-inflammatory glucocorticoid treatment on clinicopathologic, echocardiographic, and hemodynamic variables in systemically healthy dogs.
    Masters AK; Berger DJ; Ware WA; Langenfeld NR; Coetzee JF; Mochel JPM; Ward JL
    Am J Vet Res; 2018 Apr; 79(4):411-423. PubMed ID: 29583045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Experimental determination of a subantimicrobial dosage of doxycycline hyclate for treatment of periodontitis in Beagles.
    Kim SE; Kim S; Jeong M; Lee Y; Ahn JT; Park YW; Ahn JS; Lee E; Ryu DY; Seo K
    Am J Vet Res; 2013 Jan; 74(1):130-5. PubMed ID: 23270357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyl-L-proline): IV. Assessment of the repeated-dose toxicological potential of synthesized L-valyl-L-prolyl-L-proline in male and female rats and dogs.
    Nakamura Y; Bando I; Mennear JH; Bernard BK
    Int J Toxicol; 2005; 24 Suppl 4():25-39. PubMed ID: 16419577
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Milrinone. A clinical trial in 29 dogs with moderate to severe congestive heart failure.
    Keister DM; Kittleson MD; Bonagura JD; Pipers FS; Knauer KW
    J Vet Intern Med; 1990; 4(2):79-86. PubMed ID: 2187984
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase I and pharmacokinetic evaluation of the combination of orally administered docetaxel and cyclosporin A in tumor-bearing dogs.
    McEntee MC; Rassnick KM; Lewis LD; Zgola MM; Beaulieu BB; Balkman CE; Page RL
    Am J Vet Res; 2006 Jun; 67(6):1057-62. PubMed ID: 16740102
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of monotherapy with benazepril, an angiotensin converting enzyme inhibitor, in dogs with naturally acquired chronic mitral insufficiency.
    Kitagawa H; Wakamiya H; Kitoh K; Kuwahara Y; Ohba Y; Isaji M; Iwasaki T; Nakano M; Sasaki Y
    J Vet Med Sci; 1997 Jul; 59(7):513-20. PubMed ID: 9271444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of sinorphan, an endopeptidase inhibitor on severe congestive cardiac insufficiency].
    Varin J; Duboc D; Weber S; Fouchard J; Schwartz JC; Muffat-Joly M; Guérin F
    Arch Mal Coeur Vaiss; 1991 Oct; 84(10):1465-71. PubMed ID: 1662033
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reproductive study. II: Prenatal and postnatal development study with candoxatril in Sprague-Dawley rats.
    Horimoto M; Ito R; Isobe Y; Sakimura M; Tachibana M
    J Toxicol Sci; 1998 Nov; 23 Suppl 5():671-9. PubMed ID: 9891906
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of a fixed-dose combination of benazepril and pimobendan in dogs with congestive heart failure: a randomized non-inferiority clinical trial.
    King JN; Hirakawa A; Sonobe J; Otaki H; Sakakibara N; Seewald W; Forster S
    J Vet Sci; 2018 Jan; 19(1):117-128. PubMed ID: 28693297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance.
    Glaze ER; Lambert AL; Smith AC; Page JG; Johnson WD; McCormick DL; Brown AP; Levine BS; Covey JM; Egorin MJ; Eiseman JL; Holleran JL; Sausville EA; Tomaszewski JE
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):637-47. PubMed ID: 15986212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.